Lymphomas - Refresher 2020
This course will provide radiation oncologists with the up-to-date management of patients with lymphoma, including clinical decision making on who benefits from radiotherapy, the optimal dose/fractionation, and technical aspects of treatment including involved site/node radiotherapy and advanced radiation techniques. New trial data will be put in context with existing treatment paradigms, thereby providing attendees a framework on how radiotherapy for lymphoma is integrated with systemic therapies (if applicable) and diagnostic imaging, including PET/CT. Case-based studies will be integrated throughout the talk to highlight the potential role of modern radiation techniques to minimize radiation toxicity.
This activity is available from March 30, 2020, through 11:59 p.m. Eastern time on March 29, 2023.
This activity was originally recorded during ASTRO’s 2020 Annual Refresher Live Interactive Virtual Conference, March 20-22, 2020.
The activity is designed to meet the interests of radiation oncologists and radiation oncology residents.
- Recognize the key role of radiotherapy in management of patients with lymphoma, including in the primary, adjuvant, salvage, and palliative settings.
- Describe how radiotherapy for patients with lymphoma interfaces with systemic therapy.
- Describe strategies to minimize radiation toxicity, including involved site/node radiotherapy and advanced radiation techniques.
Yolanda Tseng, MD is employed by the University of Washington Medical Center and has no financial relationships with a commercial interest.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
- 1.00 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.
- No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
- No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
- ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.